Dementia risk for people 55 and older has doubled, new study finds
Dementia cases in the U.S. are expected to double by 2060, with an estimated one million people diagnosed per year, according ...
Dementia Cases in the U.S. Expected to Double by 2060, Hitting 1 Million a Year
Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.
Medscape5d
US Dementia Cases Projected to Double Within 40 Years
The number of US adults who will develop dementia each year is projected to increase from approximately 514,000 in 2020 to ...
New diagnostic criteria for LATE dementia offers hope for improved dementia care
LEXINGTON Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are at the forefront of advancing ...
STAT10h
Dementia risk, higher than thought, requires a national strategy
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
Dartmouth Health hopes to improve Alzheimer's care with new program
Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...
WFIU10d
New dementia outreach specialists connect people to treatment, care, education in their communities
All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging â€” are now required to have a ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
New evidence links dementia to problems with the brain's waste clearance system
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...